Prognostic Value of TACE With Irinotecan-loaded Drug-eluting Beads (DEBIRI) in Patients With Liver Metastases from Unresectable Colorectal Cancer
Anticancer Research · 2023
DOI: 10.21873/anticanres.16545 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Toru Ishikawa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan toruishi@ngt.saiseikai.or.jp. Hauptthemen laut MEDLINE: Antineoplastic Agents, Phytogenic, Liver Neoplasms, Carcinoma, Hepatocellular, Chemoembolization, Therapeutic. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan toruishi@ngt.saiseikai.or.jp.
- Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan.
ORCID-Profile: Toru Ishikawa
Zitieren
APA
Ishikawa, T., Imai, M., Sato, R., Jimbo, R., Kobayashi, Y., Sato, T., Iwanaga, A., Sano, T., Yokoyama, J., & Honma, T. (2023). Prognostic Value of TACE With Irinotecan-loaded Drug-eluting Beads (DEBIRI) in Patients With Liver Metastases from Unresectable Colorectal Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.16545
Vancouver
Ishikawa T, Imai M, Sato R, Jimbo R, Kobayashi Y, Sato T, et al. Prognostic Value of TACE With Irinotecan-loaded Drug-eluting Beads (DEBIRI) in Patients With Liver Metastases from Unresectable Colorectal Cancer. Anticancer Research. 2023. doi:10.21873/anticanres.16545
BibTeX
@article{Ishikawa2023,
author = {Ishikawa, Toru and Imai, Michitaka and Sato, Ryo and Jimbo, Ryo and Kobayashi, Yuji and Sato, Toshifumi and Iwanaga, Akito and Sano, Tomoe and Yokoyama, Junji and Honma, Terasu},
title = {Prognostic Value of TACE With Irinotecan-loaded Drug-eluting Beads (DEBIRI) in Patients With Liver Metastases from Unresectable Colorectal Cancer},
journal = {Anticancer Research},
year = {2023},
doi = {10.21873/anticanres.16545}
}
EUVIMED